The largest database of trusted experimental protocols

Pooled human ab serum

Manufactured by Valley Biomedical

Pooled human AB serum is a laboratory reagent composed of blood serum obtained from multiple human donors with AB blood type. It provides a source of proteins, growth factors, and other components found in human blood serum, which can be used to support the growth and maintenance of cell cultures in various research and diagnostic applications.

Automatically generated - may contain errors

2 protocols using pooled human ab serum

1

Differentiation of Huh7.5 Cells Using Human Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Huh7.5 differentiation using HS has been described previously4 . For our studies we use pooled human AB serum (Valley Biomedical (Winchester, Virginia) Sigma-Aldrich, or any other reliable provider). Pooled human serum is prepared from the serum from 80–130 healthy donors, which removes the variability we observe with individual serum samples. Since the use of human serum results in growth arrest4 , cell cultures were normally maintained in FBS-containing media as described above4 . At the time of transfer to human serum, cells were trypsinized, trypsin was inactivated with DMEM/10% FBS/penicillin/streptomycin and cells were centrifuged at 300 g. Cell pellets were then resuspended in DMEM/2% HS/penicillin/streptomycin, and plated at a density of 30–50%4 on Eppendorf cell culture plates. At confluency cells were trypsinized once more, and plated at a density of 50%. They then form confluent layers of undividing cells4 .
The differentiation process takes approximately 21 days. Cells can be trypsinized/sub-cultured for approximately 7–10 days, but continued sub-culturing beyond that leads to cell death, as the cells do not attach to cell culture plastic any more4 .
+ Open protocol
+ Expand
2

Isolation and Maintenance of Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All PBMCs used in this study were derived from de-identified apheresis products purchased from Key Biologics. PBMCs were isolated from three independent normal healthy donors by Ficoll-Paque (General Electric Company) density gradient centrifugation. All T cells were maintained AIM V medium (Life Technologies) supplemented with 5% heat-inactivated pooled human AB serum (Valley Biomedical), 300 IU/mL recombinant interleukin-2 (IL-2) (rhIL-2; Novartis Pharmaceuticals Cooperation), and 100 ng/mL recombinant human IL-15 (rhIL-15; Biologic Resources Branch, NCI, NIH) at 37°C in a humidified 5% CO2 incubator.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!